Top takeaways from the Heart in Diabetes conference

The inaugural Heart in Diabetes Conference recently wrapped up in Philadelphia. During the 3-day event, attendees discussed recent clinical trials about the risk factors, treatments and other research impacting patients with prediabetes, diabetes and metabolic syndrome.

As a courtesy to its readers, Healio Family Medicine provides some of the top news and research to come from this meeting.

Glycemic control critical factor in reducing CV risk

Solid evidence exists that improved glycemic control reduces microvascular complications in people with diabetes. Read more.

Different approach to CVD risk assessment should be taken in patients with diabetes

Models to assess CV risk in patients with diabetes often underestimate risk, but the addition of clinical tests including imaging tests and biomarkers may improve this. Read more

VIDEO: Certain antiplatelet therapies more beneficial for patients with vs. without diabetes

In this Healio video perspective, Deepak Bhatt, MD, MPH, from Brigham and Women’s Hospital, discusses his presentation on the use of antiplatelet therapy for patients with diabetes. Watch video.

Angioplasty, bypass surgery options for patients with diabetes, coronary artery disease

For patients with diabetes and multivessel coronary artery disease, coronary artery bypass grafting shows higher procedural benefit compared with percutaneous coronary intervention. Read more.

Similar mortality rates found for community-acquired, hospital-acquired acute kidney injury

Acute kidney injury is common, and community-acquired and hospital-acquired acute kidney injury lead to similar mortality rates. Read more.